Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults

SCB-1019T is a novel bivalent recombinant RSV vaccine (CHO Cell) designed to broadly neutralize the two dominant circulating strains of the virus. The SCB-1019T vaccine consists of the PreF protein subunits from the two dominant circulating strains, strain A and strain B, fused to Trimer-Tag™.

positive comparator

Placebo Comparator